Citations

Clear

6273 citation(s) found for "To, Andrew".

Abstract 4357761: Declining Mortality from Myocardial Infarction in Young and Middle-Aged Americans and the Impact of the COVID-19 Pandemic
Jabbar, Ali Bin Abdul, Klisares, Mason , Azouz, M.M., Aboeata, Ahmed, Abdul Jabbar, Ali Bin , Ismayl, Mahmoud , Azouz, Mohamed, Osborne, John, Goldsweig, Andrew M.

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4357761 Get It

Background: Acute myocardial infarction (AMI) represents a significant component of cardiovascular disease (CVD) mortality among the young and middle-aged populations of the United States (US). Research Question: To analyze the long-term trends and the impact of the COVID-19 pandemic on AMI-related mortality among the young and middle-aged populations of the US. Methods: Data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) multiple causes of death database were used to analyze death certificates from 1999 to 2023 for AMI-related deaths among the young and middle-aged population (aged 25-64) of the US. Age-adjusted mortality rates (AAMRs) per 100,000 people and associated annual percent changes (APCs) and average APC (AAPCs) were analyzed using Joinpoint regression analysis. Mortality trends were stratified by sex, race/ethnicity, and census region. Results: From 1999 to 2023, there were 970,454 AMI-related deaths among U.S. adults aged 25-64 years. The annual number of AMI-related deaths decreased from 44,040 in 1999 to 31,522 in 2023. The overall AAMR per 100,000 decreased from 31.02 deaths (95% CI, 30.73 to 31.31) in 1999 to 15.29 (95% CI, 15.11 to 15.46) in 2023 (AAPC -2.92%, 95% CI -3.22 to -2.75). The AAMR per 100,000 declined at a faster rate from 31.02 in 1999 to 19.57 in 2010 (1999-2010, APC -4.26), followed by a slower rate from 19.57 in 2010 to 16.67 in 2019 (2010-2019, APC -1.41), The declining trend was disrupted by a transient increase during the COVID-19 pandemic, with a peak AAMR of 19.73 (95% CI, 19.53 to 19.93) in 2021 (2019-2021, APC 8.52). The declining trend resumed from 2021 to 2023, with AAMR decreasing to the lowest levels of 15.29 in 2023 (2021-2023, APC -12.58). Heterogeneity across demographic and regional groups has narrowed during these 25 years. However, they are still prevalent, with men ( figure 1 ), non-Hispanic (NH) Black or African American, NH American Indian or Alaska Native ( figure 2 ), and the residents of the Southern United States ( figure 3 ) having higher mortality rates. Conclusion: Over the past 25 years, AMI-related mortality has declined in the young and middle-aged population of the US, although rates spiked during the COVID-19 pandemic before resuming their decline in 2022. While disparities among demographic and regional groups have narrowed, they still exist, necessitating comprehensive efforts to improve cardiovascular health outcomes.
Abstract 4364029: Biventricular Pressure-Volume Loop Assessment of Impella 5.5 in a Porcine Model of Myocardial Infarction
Inglis, Sara, Rahme, Serena, Witt, Tyra A. , Nagel, Mary, Tiffany, Sarrafian, Tollefsrud, Katrina, Yalamuri, Suraj , Rosenbaum, Andrew , Behfar, Atta, Tiffany, Sarrafian, Behfar, Atta

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4364029 Get It

Introduction: Microaxial flow pumps reduce mortality in myocardial infarction (MI) related cardiogenic shock (CS). The Impella 5.5 generates increased flow to provide circulatory support, and optimization relies on mechanistic understanding of pressure-volume (PV) relationships. Aim: Using a porcine model of acute MI in tandem with biventricular (BiV) PV loop conductance catheters, this study aimed to understand the impact of Impella 5.5 on BiV hemodynamics in MI CS. Methods: In 6 Domestic Yorkshire Pigs, an Impella 5.5 (J&J MedTech, NJ) was inserted percutaneously under fluoroscopic guidance via carotid or aortic access. An angioplasty balloon catheter was advanced past the first diagonal and inflated to above nominal pressure with blood flow obstruction for 90 minutes. BiV PV loop conductance catheters (Sigma-M, CD Leycom, Hengelo, The Netherlands) were inserted via femoral venous access. The left ventricle (LV) PV loop catheter is positioned via transeptal puncture using intracardiac echocardiography. BiV PV loops are generated for each level of Impella support from P1 to P7. Results: With increasing Impella 5.5 support, LV PV loops shifted to the left and right ventricular (RV) loops to the right. Without statistical significance, LV end diastolic volume (EDV) decreased by a mean of 12.3 ± 10.7% from baseline and RV EDV increased by 32 ± 40%. Native LV function decreased with increasing Impella 5.5 support, demonstrated by a reduction in stroke volume (SV) (35±13 ml to 27±14 ml; p<0.001), cardiac output (CO) derived from SV&heart rate (2.0±0.5 ml/min to 1.7±0.7 ml/min; p<0.001), and ejection fraction (EF) (37±7% to 29±12%; p<0.001). Less consistent trends were noted in peak positive dP/dt and end-systolic pressure volume relationship. Native RV function increased with higher levels of Impella 5.5 support, noted by increasing SV (27±24 ml to 41±28 ml; p=0.004), CO (1.6±1.2 ml/min to 2.3±1.4 ml/min; p=0.001), and EF (42±16% to 45±9%; p=0.04). Arterial elastance and ventriculo-arterial coupling increased in the LV from baseline to P7 (2.2±1.4 mmHg/ml to 2.8±1.0 mmHg/ml and 1.8±0.5 to 3.2±1.9, respectively; p<0.001) and decreased in the RV (1.3±0.7 mmHg/ml to 0.9±0.7 mmHg/ml (p<0.001) and 2.1±2.2 to 1.3±0.6 (p=0.004)). Conclusions: Impella 5.5 speed modulation highlights significant ventricular interdependence in the setting of acute MI. PV loop derived parameters here visualized parameters that may be utilized to improve optimization of hemodynamic support in CS.
Intravascular imaging vs. angiography alone to guide percutaneous coronary intervention in older adults: a meta-analysis of randomized controlled trials
Ibrahim, Sammudeen , Chi, Kuan‐Yu , Joseph, Meghna , Nouri, Armin, Mouslmani, Mohammad Al, Ezenna, Chidubem , Ismayl, Mahmoud , Krishna, Mrinal Murali , Akman, Zafer , Rossi, Raiza , Nouri, Armin, Damluji, Abdulla A , Goldsweig, Andrew M. , Nanna, Michael G.

Mayo Clinic

Coronary Artery Disease | November 2, 2025 | Volume: 37 | Issue: 3 | Pages: 195-205

10.1097/mca.0000000000001584 | PMID 41176629 Get It

Background Older adults undergoing percutaneous coronary intervention (PCI) face unique challenges due to complex anatomy and comorbidities. Intravascular imaging [including intravascular ultrasound (IVUS) and optical coherence tomography (OCT)] has been shown to improve PCI outcomes, but its benefits in older adults are less well established. We conducted a meta-analysis of randomized controlled trials (RCTs) to compare intravascular imaging with angiography alone to guide PCI in older adults. Methods Cochrane, PubMed, and Scopus were searched for RCTs comparing intravascular imaging (IVUS or OCT) vs. angiography alone in adults aged ≥65 years. The outcome of interest was major adverse cardiovascular events (MACE) at the longest follow-up, as defined by each trial. Subgroup analyses were performed based on intravascular imaging modality, age group, and lesion complexity. Data were pooled using random-effects models, and heterogeneity was assessed using Higgins’ I ² statistic. Results Nine RCTs ( n = 7164, intravascular imaging = 3703, angiography alone = 3461) met the inclusion criteria. Intravascular imaging significantly reduced MACE compared with angiography alone [relative risk (RR) 0.66, 95% confidence interval (CI) 0.56–0.77; P < 0.001; I ² = 0%]. IVUS demonstrated superiority over angiography alone (RR 0.55, 95% CI 0.43–0.72; P < 0.001; I ² = 0%), while OCT demonstrated only a trend toward MACE reduction (RR 0.80, 95% CI 0.62–1.02). Subgroup analyses indicated consistent benefits with intravascular imaging for adults aged ≥65 and ≥70 years, respectively, and among those with complex coronary lesions (RR 0.65, 95% CI 0.53–0.79; P < 0.001). Conclusion Intravascular imaging guidance, especially IVUS, reduces MACE in older adults undergoing PCI compared with angiography alone.
Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Du
Shi, Qian , Collisson, Eric A. , Dixon, Jesse G. , Cusnir, Mike , Winograd, Rafael , Botta, Gregory P. , Shergill, Ardaman , Ko, Andrew , Tsang, Erica S , Shi, Qian , Olive, Kenneth P , Collisson, Eric , Dixon, Jesse G , Cusnir, Mike , Winograd, Rafael , Botta, Gregory P , Shergill, Ardaman , Meyerhardt, Jeffrey A , O'Reilly, Eileen M , Ko, Andrew H , Wadlow, Raymond Couric , Meyerhardt, Jeffrey A. , O’Reilly, Eileen M.

Mayo Clinic

JCO Oncology Advances | October 31, 2025 | Volume: No volume available | Issue: 2 | Pages: No page available

10.1200/oa-25-00099 | PMID 42610096 Get It

Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
Rohrberg, Kristoffer Staal , Lopez, Juanita , Milhem, Mohammed , Blank, Christian U. , Reijers, Irene L. M. , Plummer, Ruth , Piha‐Paul, Sarina A. , Jänne, Pasi A. , Shaw, Heather M. , Debruyne, Philip R. , Lao, Cristopher , Gort, Eelke , Zhao, Yujie , Schöffski, Patrick , Chen, Andrew William , Cohen, Eric A. , Katz, Sharyn I. , Brady, Luther W. , Qutaish, Mohammed , Castro, Patricia Garrido , Pencheva, Nora , Fu, Yali , Windfeld, Kristian , Reiter, Panagiota , Amiri, Katayoun I. , Ahmadi, Tahamtan , Forssmann, Ulf , Vergote, Ignace , Lopez, Juanita S , Milhem, Mohammed M , Reijers, Irene , Thistlethwaite, Fiona , Plummer, Ruth , Piha-Paul, Sarina A , Jänne, Pasi A , Shum, Elaine , Shaw, Heather M , Debruyne, Philip R , Lao, Cristopher , Baurain, Jean-Francois , Choe, Jennifer H , Gort, Eelke , Zhao, Yujie , Jerusalem, Guy , Schöffski, Patrick , Chen, Andrew William , Cohen, Eric A , Mankowski, Walter C , Roshkovan, Leonid , Katz, Sharyn I , Kontos, Despina , Brady, Lauren K , Qutaish, Mohammed , Castro, Patricia Garrido , Pencheva, Nora , Bajaj, Gaurav , Fu, Yali , Windfeld, Kristian , Reiter, Panagiota , Jure-Kunkel, Maria , Higgs, Brandon W , Amiri, Katayoun I , Ahmadi, Tahamtan , Forssmann, Ulf , Ramalingam, Suresh S. , Vergote, Ignace , Baurain, Jean‐François , Jérusalem, Guy , Mankowski, Walter C.

Mayo Clinic

Cancer Research Communications | October 30, 2025 | Volume: 5 | Issue: 11 | Pages: 2066-2078

10.1158/2767-9764.crc-25-0359 | PMID 41166388 Get It

Abstract Purpose: AXL, a receptor tyrosine kinase related to oncogenic processes, is aberrantly expressed in various cancers and associated with treatment resistance. Enapotamab vedotin (EnaV), a novel anti-AXL human IgG1 and monomethyl auristatin E antibody–drug conjugate, demonstrated antitumor activity in preclinical models, including non–small cell lung cancer (NSCLC). This phase 1/2 study assessed the safety and preliminary efficacy of EnaV in solid tumors. Patients and Methods: This study comprised dose-escalation and dose-expansion phases; both phases investigated EnaV once every 3 weeks (Q3W) and EnaV on days 1, 8, and 15 of a 28-day cycle (3Q4W). Primary objectives determined the maximum tolerated dose (dose escalation) and safety (dose expansion). Pharmacokinetic profile, antitumor activity, and AXL expression were also assessed. Results: During dose escalation, 32 patients received EnaV Q3W; 15 received EnaV 3Q4W. The maximum tolerated dose and recommended phase 2 dose were 2.2 mg/kg in Q3W and 1.0 mg/kg in 3Q4W schedules. In dose expansion, 189 patients received EnaV Q3W; 70 received EnaV 3Q4W. Common adverse events in dose expansion included fatigue, constipation, nausea, decreased appetite, and diarrhea. Overall response rates ranged from 4.5% to 12.5% with Q3W dose schedule and from 9.1% to 11.5% with 3Q4W dose schedule. Disease control rates for NSCLC cohorts were 40.9% to 50.0%. NSCLC subset analysis demonstrated correlation between radiomics signature and disease control. The relationship between clinical activity and AXL expression was not apparent. Conclusions: EnaV had an acceptable safety profile; however, because the evaluation of antitumor activity did not show clinically meaningful responses, clinical development of EnaV was discontinued. Significance: EnaV, an anti-AXL human IgG1 and monomethyl auristatin E antibody–drug conjugate, showed single-agent antitumor activity in preclinical models. This phase 1/2 study of EnaV demonstrated a manageable safety profile and antitumor activity in selected tumor types. Further studies exploring alternative targeting modalities, patient selection, and/or combinations are needed.
The successful use of buprenorphine to manage kratom withdrawal secondary to self-treatment of opioid withdrawal
Sivakumar, Deepika, Pascual, Jennifer, Clark, Katharine , Mason, Jessica M., Walfield, Andrew L., Maldonado, Graciela , Sivakumar, Deepika, Kennedy, Maura , Hayes, Bryan D.

Mayo Clinic

Clinical Toxicology | October 30, 2025 | Volume: 63 | Issue: 11 | Pages: 1018-1019

10.1080/15563650.2025.2552436 | PMID 41166111 Get It

Effectiveness of Infliximab for Refractory Nonischemic Cerebral Enhancing Foreign-Body Granulomatous Lesions After Endovascular Therapy
Aboseif, Albert , Taha, Farris , Tagg, Nathan T. , Smith, Andrew D. , Brown, Robert D. , Pittock, Sean J. , Perez-Giraldo, Gina , McKeon, Andrew , Pittock, S J , Flanagan, E P , Brown, Robert D , Perez Giraldo, Gina S , McKeon, Andrew , Aboseif, Albert , Flanagan, Eoin P.

Mayo Clinic

Neurology | October 29, 2025 | Volume: 105 | Issue: 10 | Pages: No page available

10.1212/wnl.0000000000214345 | PMID 41160790 Get It

Developmental Differences in Myocardial Mitochondrial Reticulum Networks in the Offspring Exposed to Diabetic Pregnancy
Ayyappan, Prathapan , Gandy, Tyler C. T., Sturdevant, David , Larsen, Tricia D. , Mukuntharaj, Pradeeksha , Paulson, Andrew, Christensen, Trace , Salisbury, Jeffrey L., Baack, Michelle , Christensen, Trace A , Baack, Michelle L

Mayo Clinic

Cells | October 29, 2025 | Volume: 14 | Issue: 21 | Pages: 1698

10.3390/cells14211698 | PMID 41227343 Get It

Diabetic pregnancy increases the offspring’s risk of neonatal and adult cardiovascular disease (CVD). We previously used a rat model (Sprague–Dawley) to show that diabetic pregnancy impairs mitochondrial bioenergetics, dynamics, mitophagy, and quality control in the offspring’s heart, and we hypothesized that mitochondrial dysfunction during early development influences the adult myocardium structure to confer cardiometabolic disease risk with aging. Here, we used 3D serial block face-scanning electron microscopy (SBF-SEM) to analyze perinuclear (PN) and intrafibrillar (IF) mitochondrial networks in the left ventricular sections from control and pregestational diabetes-exposed newborn (NB) rats that were three-week-old and four-month-old. Diabetes-exposed myocardium had 50% fewer PN and 20% fewer IF mitochondria at birth but counts increased more rapidly, resulting in no difference at three weeks and 35% more PN and 49% more IF mitochondria by four months. Despite rising counts, mitochondria volumes remained significantly lower at every developmental timepoint. This shows that diabetic pregnancy causes maldevelopment of the myocardial mitochondrial reticulum which likely contributes to adult CVD.
Centering Patient Voices in Lupus Pain: A Biopsychosocial Analysis of Reddit Narratives Using Large Language Models
Walker, Andrew , Leung, Jerik , Alagappan, Aishwarya , Rajwal, Swati , Lakamana, Sahithi , Park, Tricia , Le, Nathan , Irani, Anushka, Falasinnu, Titilola , Irani, Anushka , Falasinnu, Titilola , Irani, Anushka , Walker, Andrew , Sarker, Abeed , Bozkurt, Selen

Mayo Clinic

Arthritis Care & Research | October 28, 2025 | Volume: 78 | Issue: 1 | Pages: 123-133

10.1002/acr.25687 | PMID 41147795 Get It

Objective Patients with chronic illness share their experiences in online communities and generate rich data on pain management. This study applied natural language processing methods, including large language models (LLMs), to Reddit discussions from lupus communities to characterize multidimensional pain experiences framed in the biopsychosocial model. Methods We extracted Reddit posts from the r/Lupus and r/LupusSupport subreddits posted from June 9, 2010, through December 31, 2023. Pain‐related posts were identified using a clinically informed pain lexicon. Topic modeling was used to identify thematic patterns, which were then compared with structured summaries generated by LLM instructions that were fine‐tuned using the biopsychosocial model of pain. Two reviewers conducted content analysis of the LLM‐generated summaries, evaluating thematic accuracy and coverage. Results Data from Reddit included 31,785 posts from 10,857 authors. We identified common pain complaints, management strategies, and sociocultural, affective, and nociplastic dimensions of pain. Instruction fine‐tuned LLMs produced structured summaries with an average thematic accuracy score of 3.1 of 4 (kappa = .09) and content coverage score of 2.9 of 4 (kappa = .38). Sociocultural features presented in 123 posts (33.8%), including peer support and validation (n = 106) and provider interactions or access issues (n = 35). Nociplastic pain presented in 205 posts (56.3%). Conclusion Natural language processing methods can be used to extract rich, multidimensional insights into pain experiences from online communities focused on lupus. These approaches highlight the psychological, social, and cultural facets of pain that may be underrepresented in clinical settings, supporting more patient‐centered approaches to care in rheumatology.
Assessing Critical Care Delivery Using National-Level ICU Registry Data
Kasotakis, George , Kuriyama, Akira , Smalls, Norma, Connor, Kathryn , Miller, Andrew G , Bittner, Edward A. , Temsah, Mohamad-Hani, Siddiqui, Shahla , Biswas, Saptarshi , Slain, Katherine , Akuamoah-Boateng, Kwame , Sakhuja, Ankit , Boomer, Laura A., Setliff, Erika L., Neyra, Javier A. , Rincon, Teresa , Bose, Somnath , Barwise, Amelia , Group, the Society of Critical Care Medicine (SCCM) U.S. ICU Registry Working, Barwise, Amelia K , Dempsey, Timothy , Jaehne, Anja Kathrin , Temsah, Mohamad‐Hani , Bell, Carolyn M. , Khanna, Ashish K. , Owusu, Kent A. , Alexander, Peta , Dugar, Siddharth , Cantrell, Sarah E. , Shein, Steven L. , Group, the Society of Critical Care Medicine (SCCM) U.S. ICU Registry Working

Mayo Clinic

Critical Care Medicine | October 27, 2025 | Volume: 53 | Issue: 12 | Pages: e2674-e2685

10.1097/ccm.0000000000006886 | PMID 41139471 Get It

Objective: The specialty of critical care in the United States currently lacks a single, broad, unified database. We conducted a scoping review of existing established national ICU databases, describing national and international patterns of critical care delivery. Data Sources: A systematic literature search was undertaken using MEDLINE, Embase, and Web of Science search engines. Study Selection: Projects describing national critical care delivery (including any subspecialty) published in any language were included. Titles, abstracts, and full-text manuscripts were reviewed in duplicate for inclusion. Data Extraction: National database characteristics were collected, including the number and subspecialty of ICUs, the inaugural year, data entry methodology, the number of episodes of care included, and captured clinical data elements. Data Synthesis: Of 24,003 abstracts screened, 185 manuscripts were eligible for inclusion. Thirty countries were identified as having established national ICU registries: Argentina, Australia/New Zealand, Austria, Belgium, Brazil, Canada, Denmark, Ecuador, Finland, Germany, Iceland, India, Ireland, Italy, Japan, Kenya, Malaysia, Mexico, Nepal, Netherlands, Norway, Pakistan, Paraguay, Spain, Sri Lanka, Sweden, Switzerland, United Kingdom, United States and Uruguay. Data entry commonly incorporates a combination of automated data abstraction from electronic healthcare systems and manual data entry, followed by independent validation. Frequently recorded variables include patient demographics; admission vital signs and laboratory data; comorbidities; admission source and diagnoses; ICU diagnoses, treatments, and complications; illness severity scores; and clinically relevant outcomes including discharge disposition, functional status, lengths of stay, and mortality. Conclusions: Insights and experience gained from the study of mature national ICU registries may be used to guide an equivalent U.S. multidisciplinary program aimed at benchmarking, needs assessment, quality improvement, and research facilitation